$55.2 Million is the total value of Context Capital Management, LLC's 40 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 106.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Exit | FIBROCELL WARRANTS 18.75 Strikewts | $0 | – | -15,274 | -100.0% | 0.00% | – | |
Exit | FRONTERA RESOURCES CORPrstd | $0 | – | -10,815 | -100.0% | -0.00% | – | |
Exit | FIBROCELL WARRANTS 6.25 Strikewts | $0 | – | -32,000 | -100.0% | -0.01% | – | |
Exit | GALENA BIOPHARMAwts | $0 | – | -30,000 | -100.0% | -0.01% | – | |
Exit | WTS GREEN HUNTER RESOURCES INC @$2.25 EXwrnt | $0 | – | -38,889 | -100.0% | -0.03% | – | |
Exit | KINDER MORGAN INC/DELAWARE-Pwts | $0 | – | -10,000 | -100.0% | -0.05% | – | |
CNLMU | Exit | CB PHARMA ACQUISITION-UNITunit | $0 | – | -14,900 | -100.0% | -0.19% | – |
FMCKJ | Exit | FREDDIE MAC 7.875%preferred | $0 | – | -40,000 | -100.0% | -0.20% | – |
Exit | FIBROCELL WARRANTS 2.5 Strikewts | $0 | – | -456,670 | -100.0% | -0.67% | – | |
Exit | JAKKS PACIFIC INCconv | $0 | – | -875,000 | -100.0% | -0.95% | – | |
Exit | COBALT INTERNATIONAL ENERGYconv | $0 | – | -1,300,000 | -100.0% | -1.00% | – | |
Exit | DENDREON CORPconv | $0 | – | -1,350,000 | -100.0% | -1.05% | – | |
HTWO | Exit | HF2 FINANCIAL MANAGEMENT INC | $0 | – | -157,822 | -100.0% | -2.04% | – |
Exit | TECHNOLOGY INVSTMT CAP CORPconv | $0 | – | -2,220,000 | -100.0% | -2.89% | – | |
Exit | JAKKS PACIFIC INCconv | $0 | – | -2,574,000 | -100.0% | -3.08% | – | |
Exit | CBIZ INCconv | $0 | – | -2,750,000 | -100.0% | -4.14% | – | |
SQNM | Exit | SEQUENOM INCconv | $0 | – | -4,000,000 | -100.0% | -5.15% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-04-28
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
THERAVANCE BIOPHARMA INC | 23 | Q2 2022 | 4.7% |
ENCORE CAPITAL GROUP INC | 19 | Q2 2019 | 6.2% |
INTERCEPT PHARMACEUTICALS IN | 18 | Q4 2022 | 6.2% |
INFINERA CORPORATION | 18 | Q1 2023 | 3.6% |
TESLA MTRS INC | 16 | Q1 2019 | 4.9% |
DISH NETWORK CORPORATION | 16 | Q3 2023 | 3.3% |
ENDOLOGIX INC | 15 | Q2 2019 | 11.6% |
OMEROS CORP | 15 | Q3 2023 | 3.1% |
VANGUARD TOTAL STOCK MKT ETF | 15 | Q1 2020 | 3.9% |
AMAG PHARMACEUTICALS INC | 14 | Q3 2020 | 7.7% |
View Context Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ELECTRO ENERGY INC | February 17, 2009 | 326,124 | 4.9% |
IRONCLAD PERFORMANCE WEAR CORPSold out | February 17, 2009 | 0 | 0.0% |
Jazz Technologies, Inc.Sold out | February 17, 2009 | 0 | 0.0% |
VELOCITY EXPRESS CORP | February 17, 2009 | 190,104 | 5.3% |
ATS CORP | June 17, 2008 | 723,073 | 3.6% |
Ascend Acquisition Corp.Sold out | June 16, 2008 | 0 | 0.0% |
HIGHBURY FINANCIAL INCSold out | June 16, 2008 | 0 | 0.0% |
PRIMUS TELECOMMUNICATIONS GROUP INCSold out | June 16, 2008 | 0 | 0.0% |
Good Harbor Partners Acquisition CorpSold out | February 13, 2008 | 0 | 0.0% |
InfuSystem Holdings, Inc | February 13, 2008 | 152,350 | 0.8% |
View Context Capital Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-02 |
SCHEDULE 13G | 2024-03-20 |
13F-HR/A | 2024-02-16 |
13F-HR | 2024-02-09 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-10 |
13F-HR | 2023-05-08 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-07 |
13F-HR | 2022-08-03 |
View Context Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.